Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility

被引:47
作者
Geleta, Dereje Assefa [1 ]
Megerssa, Yoseph Cherinet [2 ]
Gudeta, Adugna Negussie [3 ]
Akalu, Gizachew Taddesse [4 ]
Debele, Melaku Tesfaye [5 ]
Tulu, Kassu Desta [6 ]
机构
[1] Int Org Migrat, Addis Ababa 1000, Ethiopia
[2] Univ Addis Ababa, Coll Vet Med & Agr, Addis Ababa, Ethiopia
[3] Jigjiga Univ, Jigjiga, Ethiopia
[4] Ethiopian Med Lab Assoc, Addis Ababa, Ethiopia
[5] Int Clin Labs, Addis Ababa, Ethiopia
[6] Univ Addis Ababa, Coll Hlth Sci, Addis Ababa, Ethiopia
来源
BMC MICROBIOLOGY | 2015年 / 15卷
关键词
NPV; PPV; Sensitivity; Specificity; Xpert MTB/RIF assay; Remote health facility; RESISTANCE;
D O I
10.1186/s12866-015-0566-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Xpert MTB/RIF assay is considered as a great advance over conventional smear and culture in the diagnosis of TB and MDR-TB by simultaneously detecting M. tuberculosis and rifampicin resistance bacilli. However, very little information regarding the performance characteristics of Xpert MTB/RIF assay is available in Ethiopia. Therefore, the purpose of this study was to evaluate the performance of Xpert MTB/RIF assay compared to conventional sputum smear and culture methods for the diagnosis of pulmonary tuberculosis in remote health care facility. Methods: A paired expectorated sputum samples were obtained from 227 consecutively recruited patients with signs and symptoms suggestive of tuberculosis at Karamara hospital during December 2013 to May 2014. One of the sputum specimen was tested directly by Ziehl-Neelsen staining and Xpert MTB/RIF assay without NALC-NaOH decontamination. The other of pair of sputa specimen was cultured for isolation of TB bacilli by conventional methods. Diagnostic performance of Xpert MTB/RIF assay and AFB smear microscopy were calculated against culture as the gold standard. Results: Overall 25.5 % (58/227) samples were positive for Mycobacterium tuberculosis complex (MTBC) by MGIT and/or LJ media of which 36.2 % (21/58) and 65.5 % (35/58) were positive by AFB smear microscopy and Xpert MTB/RIF respectively. The sensitivity, specificity, as well as the positive and negative predictive value of Xpert MTB/ RIF assay were 65.5 % (95 % CI: 53.3-77.7 %), 96.3 % (95 % CI: 93.4-99.2 %), 86.4 % (95 % CI: 76.2-96.5 %), and 88.6 % (95 % CI: 83.9-93.3 %) respectively. Eighteen of 58 (31 %) cases that were smear microscopy negative, were positive by Xpert MTB/RIF assay. Conclusions: Although Xpert MTB/RIF assay demonstrated high sensitivity in detecting MTBC in sputum specimens compared with conventional AFB smear microscopy, it demonstrated suboptimal sensitivity in smear negative patients compared to conventional culture.
引用
收藏
页数:6
相关论文
共 17 条
  • [1] Intensified Tuberculosis Case-Finding in HIV-Positive Adults Managed at Ethiopian Health Centers: Diagnostic Yield of Xpert MTB/RIF Compared with Smear Microscopy and Liquid Culture
    Balcha, Taye T.
    Sturegard, Erik
    Winqvist, Niclas
    Skogmar, Sten
    Reepalu, Anton
    Jemal, Zelalem Habtamu
    Tibesso, Gudeta
    Schon, Thomas
    Bjorkman, Per
    [J]. PLOS ONE, 2014, 9 (01):
  • [2] Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
    Boehme, Catharina C.
    Nicol, Mark P.
    Nabeta, Pamela
    Michael, Joy S.
    Gotuzzo, Eduardo
    Tahirli, Rasim
    Gler, Ma Tarcela
    Blakemore, Robert
    Worodria, William
    Gray, Christen
    Huang, Laurence
    Caceres, Tatiana
    Mehdiyev, Rafail
    Raymond, Lawrence
    Whitelaw, Andrew
    Sagadevan, Kalaiselvan
    Alexander, Heather
    Albert, Heidi
    Cobelens, Frank
    Cox, Helen
    Alland, David
    Perkins, Mark D.
    [J]. LANCET, 2011, 377 (9776) : 1495 - 1505
  • [3] A Diagnostic Accuracy Study of Xpert®MTB/RIF in HIV-Positive Patients with High Clinical Suspicion of Pulmonary Tuberculosis in Lima, Peru
    Carriquiry, Gabriela
    Otero, Larissa
    Gonzalez-Lagos, Elsa
    Zamudio, Carlos
    Sanchez, Eduardo
    Nabeta, Pamela
    Campos, Miguel
    Echevarria, Juan
    Seas, Carlos
    Gotuzzo, Eduardo
    [J]. PLOS ONE, 2012, 7 (09):
  • [4] Comparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary Tuberculosis
    Causse, Manuel
    Ruiz, Pilar
    Bautista Gutierrez-Aroca, Juan
    Casal, Manuel
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (08) : 3065 - 3067
  • [5] Cepheid, 2011, GEN DX SYST XP MTB R
  • [6] Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
    Dorman, Susan E.
    Chihota, Violet N.
    Lewis, James J.
    Shah, Maunank
    Clark, David
    Grant, Alison D.
    Churchyard, Gavin J.
    Fielding, Katherine L.
    [J]. PLOS ONE, 2012, 7 (08):
  • [7] Ethiopian Health and Nutrition Research Institute, 2013, ETH POP BAS NAT TB P
  • [8] Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
    Lawn, Stephen D.
    Brooks, Sophie V.
    Kranzer, Katharina
    Nicol, Mark P.
    Whitelaw, Andrew
    Vogt, Monica
    Bekker, Linda-Gail
    Wood, Robin
    [J]. PLOS MEDICINE, 2011, 8 (07)
  • [9] Scaling up interventions to achieve global tuberculosis control: progress and new developments
    Raviglione, Mario
    Marais, Ben
    Floyd, Katherine
    Loennroth, Knut
    Getahun, Haileyesus
    Migliori, Giovanni B.
    Harries, Anthony D.
    Nunn, Paul
    Lienhardt, Christian
    Graham, Steve
    Chakaya, Jeremiah
    Weyer, Karin
    Cole, Stewart
    Kaufmann, Stefan H. E.
    Zumla, Alimuddin
    [J]. LANCET, 2012, 379 (9829) : 1902 - 1913
  • [10] Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study
    Scott, Lesley E.
    McCarthy, Kerrigan
    Gous, Natasha
    Nduna, Matilda
    Van Rie, Annelies
    Sanne, Ian
    Venter, Willem F.
    Duse, Adrian
    Stevens, Wendy
    [J]. PLOS MEDICINE, 2011, 8 (07):